Healthcare: NAFDAC Cautions Against Consumption, Distribution Of U.S Infant Formulas - Liberty TV/Radio - News - Voice For All! Vision For Alll!
Publisher (J.T)
October 11, 2021
The formulas from the company were reported to have insufficient iron levels and did not meet up with other requirements of the US Food and Drug Administration, US-FDA.
NAFDAC Director General Moji Adeyeye in a statement said the agency had received information from the US-FDA on the recall of certain infant Formulas.
She also noted that the recalled products were sold under the brand names HiPP, Holle, Bioland and Kendamil, adding that they were recalled because the required pre-market notifications for these new infant formulas had not been submitted to the FDA.
Adeyeye said the products contained less than one milligram of iron per 100 calories, and that the eight infant formula product labels failed to have the required ingredient, including not being labeled as required by Code of Federal Regulations Title 21.
The NAFDAC Boss explained that inadequate intake of iron at infancy may lead to anaemia, iron deficiency which, if untreated, has irreversible cognitive and functional development outcomes.